Objective: Penile cancer services were centralised in England in 2002. Has this had an impact on treatments for penile cancer and survival? Patients and methods: All cases of penile cancer from 1990 to 2009 were identified from national cancer registry data. Mortality data were obtained from the Office for National Statistics and survival data were extracted from a national population-based database, the Cancer Information System. Socioeconomic deprivation was calculated using a national income deprivation score and surgical treatments were obtained from Hospital Episode Statistics (HES) data. Results: The number of penile cancer cases recorded rose from 300 to 400 per year during the early period of centralisation. There was a significant rise in the age-standardised incidence of penile cancer from 1.2 per 100,000 to 1.4 per 100,000 during this period. Mortality remained stable at 0.3 per 100,000. One-year and five-year relative survival remained stable after centralisation at 88% and 72% respectively. The incidence and mortality of penile cancer was significantly higher in the most deprived quintile of the population. Following centralisation, the number of total penile amputations was low at 11% but only 39% of men were recorded as having lymph node surgery, although this may reflect poor compliance with coding rather than true practice. Conclusions: The incidence of penile cancer in England is rising, but mortality and survival remains stable. Incidence and mortality is higher in more deprived areas, and greater public awareness of this disease and its risk factors are needed. By 2009, rates of penile amputation were low but potentially the proportion of lymph-node surgery remained low. This may change with the uptake of inguinal sentinel lymph-node sampling.
Introduction
Penile cancer is rare, with an incidence <1 per 100,000 in Europe and North America. 1 Centralisation was recommended in England in 2002 by the National Institute for Clinical Excellence. 2 Each penile cancer supranetwork should have a referral population of at least 4 million with a minimum of 25 new cases of penile cancer managed each year. Centralisation has resulted in greater use of penile-preserving surgery with reconstruction, attempting to preserve penile form and function as much as possible. 3 In addition, inguinal sentinel lymph-node sampling has been introduced, 4,5 after pioneering work from Amsterdam. 6 This technique significantly reduces the morbidity of inguinal node surgery whilst providing accurate staging information. The aim of this study was to use routine data sources to assess epidemiological and operative trends during the early years of penile cancer centralisation in England.
Patients and methods
All cases of penile cancer (International Classification of Diseases, tenth revision (ICD)-10 C60) and penile intraepithelial neoplasia (PeIN) (ICD-10 D074) diagnosed in England between 1990 and 2009 were extracted from the National Cancer Data Repository (NCDR).
Survival data were extracted from the Cancer Information System (CIS) 1990-2009, an online data system now superseded by CancerData. The survival reported here is all-cause relative survival. This method accounts for age, gender and socioeconomic background and presents survival as a percentage of the expected survival rates for that cohort (i.e. a relative survival of 50% is double the background mortality rate).
Disease-specific mortality was obtained from the Office for National Statistics (ONS) for 1995-2009, counting all cases for which penile cancer was recorded as the underlying cause of death. Penile cancer treatments were identified from Hospital Episode Statistics (HES) data from 2005 to 2009, using the Office of Population Censuses and Surveys (OPCS) codes listed below. Total amputation of penis (OPCS code N261) is recorded. Unfortunately, penilepreserving surgery was not accurately coded as it could be coded as partial amputation (OPCS N262, N268-N269) or excision of lesion of penis (OPCS N271-N273, N278-N279). Lymph node surgery was coded as either block dissection of lymph nodes (T851-T859) or biopsy or excision of lymph nodes (T871-T879). Unfortunately, coding for whether procedures were inguinal (Z616) or pelvic (O141) was extremely poor. Data on radiotherapy and chemotherapy were not available for this time period.
Socioeconomic deprivation was defined using the income deprivation score of the Department of Communities and Local Government Indices of Deprivation. 7 Rates were age-standardised using the 1976 European standard population.
This study was limited by the limitations of the databases used. All data collection was prospective, but our data extraction was retrospective. CIS survival data do not record the cause of death. ONS mortality data are complete, including the cause of death, but are anonymous. Recording of staging and treatment data in NCDR and CIS is poor. Treatment data from HES are dependent on the accuracy of hospital coding, and unfortunately penile-preserving surgery is not accurately recorded as it does not have a specific OPCS code. These limitations must be carefully considered when interpreting the results below, and in particular make it difficult to draw any strong conclusions from the treatment data due to lack of detailed codes for the procedures performed. A central audit repository for penile cancer, as currently exists for other urological tumour types/procedures but not for penile cancer, would potentially provide more robust data and allow stronger conclusions.
Results

Incidence
There has been an increase in the incidence of penile cancer in England since centralisation of penile cancer management to supranetwork centres ( Figure 1 . This rise mainly occurred in the 60-to 69-year-old age group. There has also been a significant increase in the incidence of PeIN over these non-overlapping three-year periods (p < 0.05) rising from 0.3 per 100,000 to 0.5 per 100,000. This rise has been seen across all age groups. The incidence of penile cancer is significantly higher in the most deprived quintile of population compared to the least deprived (p < 0.05) (Figure 2 ).
Mortality and survival
Age-standardised mortality rates have remained fairly constant since centralisation at around 0.3 per 100,000 ( Figure 1 ). Mortality rates for the most deprived quintile of 
Penile and nodal surgery
Between 2005 and 2009, 2030 penile cancers were registered and 1760 (87%) had surgery. There is no OPCS code for glansectomy and some cases were coded as other operations of penis. Total amputation was performed in 215 patients, 11% of the total. A total of 836 men (41%) had a partial amputation and 669 (33%) had excision of penile lesion. The number of total amputations was similar year on year from 2005 to 2009 (Table 1) .
Men in the most deprived quintile had a significantly higher total amputation rate, 13.9% (p < 0.05), compared to the other quintiles ( Figure 4 ). There was no significant difference between deprivation quintiles for partial amputation.
According to HES data, lymph-node surgery, either biopsy/excision or block dissection, was performed in 794 men (39%) overall. This proportion was higher in men having total amputation (65%) and partial amputation (48%). Rates of lymph-node surgery did not increase during 2005-2009 and the first and only time that lymph-node biopsy/excision was used more frequently than block dissection was in 2009 ( Figure 5 ). Unfortunately, coding for whether lymph-node procedures were inguinal (Z616) or pelvic (O141) was extremely poor and perhaps reflects poor compliance with coding in general for lymph-node surgery.
Discussion
The incidence of penile cancer in England has been rising. This has been observed in other studies 8, 9 and in other countries, such as Australia 9 and Denmark. 10 However, this is not the case in all developed countries, with the incidence being fairly stable over the same time period in the United States. 9 There are several possible causes behind this rise in incidence in England. Infection with human papilloma virus (HPV) is a known risk factor for penile cancer and it is found in about 40%-45% of penile cancers and 80%-100% of cases of PeIN. 11 Rising rates of HPV infection 12 may therefore partly explain the rise in incidence of penile cancer and PeIN. Another factor is that infant circumcision reduces the risk of developing penile cancer and rates of infant circumcision in England have been falling. 13, 14 An additional reason for the large rise in cases of PeIN is better detection and awareness of the condition; centralisation of penile cancer services has had an impact on this and may also have improved reporting of penile cancer cases to national databases. Despite the rise in penile cancer incidence throughout the 2000s, the mortality and survival rates remained stable. Whilst it is disappointing that centralisation has not had an impact on survival, one-year survival is unlikely to be significantly changed as this represents advanced disease at presentation and there have been few advances in the effectiveness of chemotherapy in penile cancer. The five-year survival figures in this study represent only the very early period of centralisation. Evidence has been presented that shows at least a 7% improvement in five-year survival in penile cancer in one region of England since centralisation. 15 This study highlights the impact of deprivation on the incidence, mortality and resulting surgical options for penile cancer. In England, the healthcare system is free and easy to access, and therefore these differences are unlikely to be due to inequalities in healthcare access. However, they may reflect differences in public awareness of the condition, embarrassment and willingness to seek medical advice early. It may also be that risk factors for penile cancer are more prevalent in areas of higher deprivation.
Smoking is a risk factor and is significantly higher in lower socioeconomic groups. 16 High-risk HPV has a higher rate in women from deprived areas. 17 The higher mortality rate and higher rate of total penile amputation amongst the most deprived quintile of the population suggest that the disease is more advanced at presentation too, although as previously stated staging data do not reliably exist in national databases to assess this further.
The data on penile surgery are limited since there is no code for glansectomy. The number of radical penectomies appears to have remained stable from 2005 to 2009 at about 40-50 cases per year, 11% of the total number of recorded penile cancer operations. It is difficult to draw any other conclusions on primary penile cancer treatments received and proportion of penile-preserving surgery due to the lack of specific codes. Only 39% of patients are recorded as having lymph-node surgery, with a similar proportion having the surgery each year from 2005 to 2009. The proportion of men having lymph-node surgery following radical penectomy was higher at 65%. This suggests case selection, with men with more advanced disease having lymph-node surgery. Inguinal sentinel lymph-node sampling was introduced as a technique for nodal staging in penile cancer following centralisation of penile cancer services in England. 4, 5 It is associated with a significantly lower morbidity than full groin dissection at 7.6%. 5 This may explain the rise in lymph-node biopsy/excision in 2009, when the technique was starting to become available in penile cancer centres. However, again it is difficult to draw strict conclusions from this as the low number of procedures may be due to poor compliance with coding rather than observation being the preferred approach to impalpable inguinal nodes, especially since coding for whether lymph-node procedures were inguinal or pelvic was extremely poor. A central audit repository for penile cancer, as currently exists for other urological tumour types/ procedures but not for penile cancer, would potentially provide more robust data and allow stronger conclusions with respect to current treatment strategies and allow bench-marking which is not possible with HES data due to the lack of codes for penile-preserving surgery.
Conclusion
During the early years of centralisation of penile cancer services the incidence of penile cancer rose and mortality and survival remained static. The incidence, mortality and rate of total penile amputation was higher in more deprived areas, and more work needs to be done in promoting awareness of this disease and its associated risk factors. Total penile amputation rates were low at 11%. However, the rate of lymph-node surgery was potentially low at 39%, although this may reflect problems with coding. If a true figure, the rate should rise following the introduction of inguinal sentinel lymph-node sampling in several penile cancer centres.
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